List of Tables
Table 1. Global RNA-Targeted Small Molecules Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of mRNA Translation Regulation
Table 3. Key Players of RNA Splicing Modification
Table 4. Key Players of Direct RNA Targeting
Table 5. Key Players of Indirect RNA Targeting - Epitranscriptomics
Table 6. Global RNA-Targeted Small Molecules Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global RNA-Targeted Small Molecules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global RNA-Targeted Small Molecules Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global RNA-Targeted Small Molecules Market Share by Region (2020-2025)
Table 10. Global RNA-Targeted Small Molecules Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global RNA-Targeted Small Molecules Market Share by Region (2026-2031)
Table 12. RNA-Targeted Small Molecules Market Trends
Table 13. RNA-Targeted Small Molecules Market Drivers
Table 14. RNA-Targeted Small Molecules Market Challenges
Table 15. RNA-Targeted Small Molecules Market Restraints
Table 16. Global RNA-Targeted Small Molecules Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global RNA-Targeted Small Molecules Market Share by Players (2020-2025)
Table 18. Global Top RNA-Targeted Small Molecules Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Targeted Small Molecules as of 2024)
Table 19. Ranking of Global Top RNA-Targeted Small Molecules Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by RNA-Targeted Small Molecules Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of RNA-Targeted Small Molecules, Headquarters and Area Served
Table 22. Global Key Players of RNA-Targeted Small Molecules, Product and Application
Table 23. Global Key Players of RNA-Targeted Small Molecules, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA-Targeted Small Molecules Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2020-2025)
Table 27. Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2026-2031)
Table 29. Global RNA-Targeted Small Molecules Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2020-2025)
Table 31. Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2026-2031)
Table 33. North America RNA-Targeted Small Molecules Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America RNA-Targeted Small Molecules Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America RNA-Targeted Small Molecules Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe RNA-Targeted Small Molecules Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe RNA-Targeted Small Molecules Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe RNA-Targeted Small Molecules Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific RNA-Targeted Small Molecules Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America RNA-Targeted Small Molecules Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America RNA-Targeted Small Molecules Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America RNA-Targeted Small Molecules Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa RNA-Targeted Small Molecules Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2026-2031) & (US$ Million)
Table 48. Accent Therapeutics Company Details
Table 49. Accent Therapeutics Business Overview
Table 50. Accent Therapeutics RNA-Targeted Small Molecules Product
Table 51. Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2020-2025) & (US$ Million)
Table 52. Accent Therapeutics Recent Development
Table 53. Anima Biotech Inc. Company Details
Table 54. Anima Biotech Inc. Business Overview
Table 55. Anima Biotech Inc. RNA-Targeted Small Molecules Product
Table 56. Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2020-2025) & (US$ Million)
Table 57. Anima Biotech Inc. Recent Development
Table 58. Arrakis Pharmaceuticals Company Details
Table 59. Arrakis Pharmaceuticals Business Overview
Table 60. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product
Table 61. Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2020-2025) & (US$ Million)
Table 62. Arrakis Pharmaceuticals Recent Development
Table 63. Epics Therapeutics Company Details
Table 64. Epics Therapeutics Business Overview
Table 65. Epics Therapeutics RNA-Targeted Small Molecules Product
Table 66. Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2020-2025) & (US$ Million)
Table 67. Epics Therapeutics Recent Development
Table 68. Expansion Therapeutics Company Details
Table 69. Expansion Therapeutics Business Overview
Table 70. Expansion Therapeutics RNA-Targeted Small Molecules Product
Table 71. Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2020-2025) & (US$ Million)
Table 72. Expansion Therapeutics Recent Development
Table 73. Gotham Therapeutics Company Details
Table 74. Gotham Therapeutics Business Overview
Table 75. Gotham Therapeutics RNA-Targeted Small Molecules Product
Table 76. Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2020-2025) & (US$ Million)
Table 77. Gotham Therapeutics Recent Development
Table 78. H3 Biomedicine Company Details
Table 79. H3 Biomedicine Business Overview
Table 80. H3 Biomedicine RNA-Targeted Small Molecules Product
Table 81. H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2020-2025) & (US$ Million)
Table 82. H3 Biomedicine Recent Development
Table 83. Ribometrix Company Details
Table 84. Ribometrix Business Overview
Table 85. Ribometrix RNA-Targeted Small Molecules Product
Table 86. Ribometrix Revenue in RNA-Targeted Small Molecules Business (2020-2025) & (US$ Million)
Table 87. Ribometrix Recent Development
Table 88. Skyhawk Therapeutics Company Details
Table 89. Skyhawk Therapeutics Business Overview
Table 90. Skyhawk Therapeutics RNA-Targeted Small Molecules Product
Table 91. Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2020-2025) & (US$ Million)
Table 92. Skyhawk Therapeutics Recent Development
Table 93. STORM Therapeutics Company Details
Table 94. STORM Therapeutics Business Overview
Table 95. STORM Therapeutics RNA-Targeted Small Molecules Product
Table 96. STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2020-2025) & (US$ Million)
Table 97. STORM Therapeutics Recent Development
Table 98. Twentyeight-Seven Therapeutics Company Details
Table 99. Twentyeight-Seven Therapeutics Business Overview
Table 100. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product
Table 101. Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2020-2025) & (US$ Million)
Table 102. Twentyeight-Seven Therapeutics Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. RNA-Targeted Small Molecules Picture
Figure 2. Global RNA-Targeted Small Molecules Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global RNA-Targeted Small Molecules Market Share by Type: 2024 VS 2031
Figure 4. mRNA Translation Regulation Features
Figure 5. RNA Splicing Modification Features
Figure 6. Direct RNA Targeting Features
Figure 7. Indirect RNA Targeting - Epitranscriptomics Features
Figure 8. Global RNA-Targeted Small Molecules Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global RNA-Targeted Small Molecules Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Laboratories Case Studies
Figure 12. Phamacy Case Studies
Figure 13. RNA-Targeted Small Molecules Report Years Considered
Figure 14. Global RNA-Targeted Small Molecules Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global RNA-Targeted Small Molecules Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global RNA-Targeted Small Molecules Market Share by Region: 2024 VS 2031
Figure 17. Global RNA-Targeted Small Molecules Market Share by Players in 2024
Figure 18. Global Top RNA-Targeted Small Molecules Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Targeted Small Molecules as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by RNA-Targeted Small Molecules Revenue in 2024
Figure 20. North America RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America RNA-Targeted Small Molecules Market Share by Country (2020-2031)
Figure 22. United States RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe RNA-Targeted Small Molecules Market Share by Country (2020-2031)
Figure 26. Germany RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific RNA-Targeted Small Molecules Market Share by Region (2020-2031)
Figure 34. China RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America RNA-Targeted Small Molecules Market Share by Country (2020-2031)
Figure 42. Mexico RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa RNA-Targeted Small Molecules Market Share by Country (2020-2031)
Figure 46. Turkey RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE RNA-Targeted Small Molecules Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Accent Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2020-2025)
Figure 50. Anima Biotech Inc. Revenue Growth Rate in RNA-Targeted Small Molecules Business (2020-2025)
Figure 51. Arrakis Pharmaceuticals Revenue Growth Rate in RNA-Targeted Small Molecules Business (2020-2025)
Figure 52. Epics Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2020-2025)
Figure 53. Expansion Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2020-2025)
Figure 54. Gotham Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2020-2025)
Figure 55. H3 Biomedicine Revenue Growth Rate in RNA-Targeted Small Molecules Business (2020-2025)
Figure 56. Ribometrix Revenue Growth Rate in RNA-Targeted Small Molecules Business (2020-2025)
Figure 57. Skyhawk Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2020-2025)
Figure 58. STORM Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2020-2025)
Figure 59. Twentyeight-Seven Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
